Evidence map›Paper›PMID 41777694›Full record

Trial reportOpen forum infectious diseases2026

Frequency and Predictors of Positive Follow-up Blood Cultures in Patients with Streptococcal Bacteremia.

Samantha R Tuma, Cristina Corsini Campioli, Kristin Cole, Kellie N Arensman Hannan

Abstract readClinical Trial
In one paragraph

Trial report in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samantha R TumaDepartment of Pharmacy, Mayo Clinic Health System, Mankato, Minnesota, USA.
Cristina Corsini CampioliDivision of Infectious Diseases, Mayo Clinic Health System, Mankato, Minnesota, USA.ORCID https://orcid.org/0000-0003-0976-7905
Kristin ColeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-8783-0191
Kellie N Arensman HannanDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-0200-1782

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Follow-up blood cultures (FUBCs) for streptococcal bacteremia are infrequently positive and may not provide sufficient clinical impact to justify the time and resources expended for their routine use. We aimed to evaluate the frequency of and risk factors for positive FUBCs in patients with streptococcal bacteremia and to compare clinical outcomes among patients with or without positive FUBCs. Methods: We retrospectively reviewed hospitalized patients with streptococcal bacteremia from September 2023 to June 2024 within a multisite health system. Patients ≥18 years old with ≥1 positive blood culture for a Results: We included 454 patients, with 48 (10.6%) having positive FUBCs. The rate of positivity ranged from 0% for Conclusions: Positive FUBCs were infrequent for

Indexed as

bacteremiablood culturesstreptococcal bacteremiaStreptococcus

Identifiers

PMID41777694
PMCPMC12951071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.